Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
License agreement supports Madrigal’s pipeline strategy to develop innovative combination treatments for…
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk…
Altizon Launches APEX Alliance for Azure channel partners
Altizon Launches APEX Alliance — Altizon Partner EXcellence Alliance — to Accelerate…
Leo Cancer Care Receives FDA 510(k) Clearance for Marie – A Revolutionary Upright Radiotherapy Platform
MIDDLETON, Wis., July 29, 2025 /PRNewswire/ -- Leo Cancer Care, a leader in…
Blockchain for Good Alliance Leads Global Digital Cooperation at UN IGF 2025
DUBAI, UAE, July 29, 2025 /PRNewswire/ -- The Blockchain for Good Alliance…
Tata Communications Paves Way for Amazon Web Services’ Advanced AI-Optimised Network in India
MUMBAI, India, July 29, 2025 /PRNewswire/ -- Tata Communications, a leading global communications…
FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: ALZHEIMER’S ASSOCIATION RELEASES ITS FIRST CLINICAL PRACTICE GUIDELINE FOR BLOOD-BASED BIOMARKER TESTS
Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in…
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker…
OXIO Recognized with Frost & Sullivan’s 2025 Global Telecom-as-a-Service Transformational Innovation Leadership Recognition for Redefining Connectivity Through Cloud-Native Innovation
Recognized for its cloud-native Telecom-as-a-Service (TaaS) platform and core network, OXIO leads…
Winners in Second Annual Stevie Awards for Technology Excellence Announced
Winners to Be Celebrated at a Ceremony in New York on September…
